Creates the Medical Research Supply Assurance and Trade Resilience Act to safeguard critical research and medical supply chains against global trade disruptions.

This bill establishes the Medical Research Supply Assurance and Trade Resilience Act to protect Alabama's medical and research supply chains from global trade disruptions. It creates a grant program for eligible hospitals, universities, and biotechnology companies facing increased costs or shortages due to trade instability, allowing funds to be used for stockpiling supplies or developing domestic alternatives. The bill also requires the Alabama Department of Public Health to maintain a strategic reserve of essential supplies like diagnostic kits and protective equipment, and establishes an advisory board to assess supply chain vulnerabilities and recommend policy changes. A dedicated state fund will be created to finance these grants and reserve operations, with the program taking effect on October 1, 2026.